Authors:
Testaz, S
Jarov, A
Williams, KP
Ling, LE
Koteliansky, VE
Fournier-Thibault, C
Duband, JL
Citation: S. Testaz et al., Sonic hedgehog restricts adhesion and migration of neural crest cells independently of the Patched-Smoothened-Gli signaling pathway, P NAS US, 98(22), 2001, pp. 12521-12526
Authors:
de Fougerolles, AR
Chi-Rosso, G
Bajardi, A
Gotwals, P
Green, CD
Koteliansky, VE
Citation: Ar. De Fougerolles et al., Global expression analysis of extracellular matrix-integrin interactions in monocytes, IMMUNITY, 13(6), 2000, pp. 749-758
Authors:
Lutgens, E
Cleutjens, KBJM
Heeneman, S
Koteliansky, VE
Burkly, LC
Daemen, MJAP
Citation: E. Lutgens et al., Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype, P NAS US, 97(13), 2000, pp. 7464-7469
Authors:
de Fougerolles, AR
Sprague, AG
Nickerson-Nutter, CL
Chi-Rosso, G
Rennert, PD
Gardner, H
Gotwals, PJ
Lobb, RR
Koteliansky, VE
Citation: Ar. De Fougerolles et al., Regulation of inflammation by collagen-binding integrins alpha 1 beta 1 and alpha 2 beta 1 in models of hypersensitivity and arthritis, J CLIN INV, 105(6), 2000, pp. 721-729
Authors:
Zheng, H
Wang, JR
Koteliansky, VE
Gotwals, PJ
Hauer-Jensen, M
Citation: H. Zheng et al., Recombinant soluble transforming growth factor beta type II receptor ameliorates radiation enteropathy in mice, GASTROENTY, 119(5), 2000, pp. 1286-1296
Authors:
George, J
Wang, SS
Sevcsik, AM
Sanicola, M
Cate, RL
Koteliansky, VE
Bissell, DM
Citation: J. George et al., Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform, AM J PATH, 156(1), 2000, pp. 115-124
Authors:
Wang, QJ
Wang, YJ
Hyde, DM
Gotwals, PJ
Koteliansky, VE
Ryan, ST
Giri, SN
Citation: Qj. Wang et al., Reduction of bleomycin induced lung fibrosis by transforming growth factorbeta soluble receptor in hamsters, THORAX, 54(9), 1999, pp. 805-812
Authors:
George, J
Roulot, D
Koteliansky, VE
Bissell, DM
Citation: J. George et al., In vivo inhibition of rat stellate cell activation by soluble transforminggrowth factor beta type II receptor: A potential new therapy for hepatic fibrosis, P NAS US, 96(22), 1999, pp. 12719-12724
Authors:
Smith, JD
Bryant, SR
Couper, LL
Vary, CPH
Gotwals, PJ
Koteliansky, VE
Lindner, V
Citation: Jd. Smith et al., Soluble transforming growth factor-beta type II receptor inhibits negativeremodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth, CIRCUL RES, 84(10), 1999, pp. 1212-1222